Pharmaceutical

Skyline wins orphan drug designation for retinitis pigmentosa gene therapy

There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.

Sep 4, 2024 - 04:00
Skyline wins orphan drug designation for retinitis pigmentosa gene therapy
There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.
Read the original article

Tags:

Previous Article

Ocaliva approval in Europe withdrawn following data re-assessment

Next Article

UK NHS launches vaccine programme for RSV

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Le...

Sep 10, 2024

Methadone treatment gets first major update in over 20 years

Methadone treatment gets first major update in over 20 ...

Feb 1, 2024

Innovations in air filters: How a simple filter solution is key to reducing energy consumption

Innovations in air filters: How a simple filter solutio...

Apr 4, 2023